The invention generally relates to devices for cardiovascular treatment. More specifically, the invention generally relates to devices for percutaneous heart valve replacement/implantation.
Valvular heart disease is common and involves considerable mortality and morbidity. Surgical replacement of the failing valve is the treatment of choice when the disease progresses and certain criteria are fulfilled. However, it is not uncommon patients fulfilling the criteria for this treatment to be rejected due to a perceived unacceptably high surgical risk for a variety of reasons such as advanced age and comorbidities. For some it is their decision to deny this treatment. These factors drove the development of prosthetic heart valve devices that can be implanted percutaneously with guiding catheters. Many such devices for the treatment of aortic valve stenosis have gained regulatory approvals and are already successfully and widely used offering clinical and survival benefits in many patients. Recently, we have seen the first device gaining regulatory approval for the percutaneous treatment of aortic valve insufficiency.
Aortic and mitral valve disease (stenosis and/or insufficiency) are equally common but despite the success in developing percutaneous prosthetic valves for the aortic valve, developing a device for percutaneously replacing the mitral valve have been challenging and problematic. The main reason is the much more complex and uneven anatomy of the mitral valve.
Apparently, the development of such a device for the percutaneous replacement of the mitral valve would be of great benefit for many patients.
This invention provides numerous alternative solutions to overcome these problems and develop a successful percutaneously delivered prosthetic mitral valve. Some of the solutions described could be used for similar prosthetic devices for implantation in other heart valves.
The invention relates to a prosthetic heart valve for an endoprosthesis used in the treatment of a stenotic heart valve and/or a heart valve insufficiency. The prosthetic heart valve comprises a plurality of leaflets, which consist of a natural and/or synthetic material and are being able to switch between their open and close position in response to the blood flow through the heart. The leaflets are attached into a collapsible wire valve frame involving a stent part and a wire mesh part that complement each other in many ways. The frame has a body that defines a lumen to its inside. The exterior portion of the frame has features that serve for its conformation and stabilization/anchoring in the anatomic structures it contacts. When the endoprosthesis apparatus is expanded within the intended failing native heart valve it replaces it and resumes its function.
The endoprosthesis is contained in a sheathed capsule and is inserted into the body and advanced to the intended location with a delivery system for percutaneously deploying a prosthetic heart valve. This system apart from the sheathed capsule includes an inner shaft assembly, and a handle maintaining control knobs that enable independent movement of the various parts of the sheathed capsule and the endoprosthesis. The handle functions allow for gradual release and deployment of the endoprosthesis, but also can recapture the endoprosthesis and safely remove it out of the body even after its complete deployment to its full functional status.
Transcatheter Mitral Valve
This prosthetic heart valve and its delivery system are intended for use in the treatment of mitral valve insufficiency and/or mitral valve stenosis. The delivery method is retrograde (the approach of the diseased mitral valve is achieved from within the left ventricle-transapical access and against the flow of the blood) or antegrade (the approach of the diseased mitral valve is achieved from within the left atrium after direct surgical approach or transeptal puncture and along with the flow of the blood), with the use of specifically designed for each access delivery systems.
The endoprosthesis comprises of a plurality of leaflets attached to a collapsible wire frame. This frame integrates a stent part and a braided and/or flat wire mesh part that complement each other in many ways. The combination of these two different resources in building the frame of the transcatheter valves described in this invention is very important and it is believed to solve many of the problems encountered to date for the development of a successful percutaneous prosthetic mitral valve. The stent part towards its ventricular end and the wire mesh part towards its atrial end. The wire mesh surrounds the stent at the atrial end and forms a body around the stent extending beyond the atrial end. According to certain embodiments of the present invention, the wire mesh extends also longitudinally towards the ventricular end of the stent forming again a body around the stent. There are limitless combinations of the relative length proportions of the endoprosthesis these parts may occupy, and they may overlap. It can have several standardized shapes and sizes. It can even be custom made based on measurements from the patient's anatomy obtained by medical imaging.
The outer parts of the wire mesh towards the atrium may be braided or flat. The rest of the wire mesh is braided. The stent part that will cover at least the annulus level has a sealing skirt from suitable material. The stent part may be cylindrical or conical (and may have a flaring towards the ventricle in order to withstand the excessive systolic forces exerted on the device with every heart beat). The wire mesh part can incorporate a fabric or other sealing material to make it instantly impermeable.
The stent part may be made of collapsible nitinol, stainless steel or other material and can self-expand. The wire mesh may be made of collapsible nitinol, stainless steel or other material and can self-expand. The advantages of the stent component is that it has maximal radial force and thus can appose and stabilize the frame optimally in areas of the mitral valve this is needed (such as the annulus area). It also provides the areas at which the prosthetic valve leaflets are attached and other structures described later. The wire mesh on the other hand, can better conform and adapt to areas of uneven and unpredictable anatomy and offer optimal sealing of unwanted blood flow by doing so. The shutting of unwanted blood flow can be instant when fabric or other components are incorporated into or on the mesh. The flat wire mesh can expand to larger diameters and reach longer where needed without occupying large volumes. The braided wire mesh may expand less but it self-adjusts perfectly to fill in restrained spaces (such as spaces between the mitral valve annulus and the stent part of the frame) and to assume the shape of the anatomy it apposes to (such as the mitral valve annulus).
The endoprosthesis frame apposes to the intended area and its anatomically designed shape together with its radial strength and its other supporting features allow it to steadily fix. In addition, the frame has particular features on its outer surface that allow deploying the endoprosthesis at the anatomically appropriate area. The frame also allows for degrees of auto-adjustment towards the anatomically appropriate area/plane. Besides the integration of a stent and a wire mesh to form the frame of the endoprosthesis, the second most important feature in the invented solutions presented in the following sections is the provision of particular components of the stent to guide and retain the device to the anatomically correct deployment position by tracking these components behind the native mitral valve leaflets and capturing them wide-open (
The valve leaflets can consist of a natural and/or synthetic material and are being able to switch between their open and close position in response to the blood flow through the mitral valve. Their fixed sides are seamed or attached with other means at the wire frame of the endoprosthesis (such as the stent ring end and the interior native valve leaflet enveloping elements). They start to function when the wire mesh part of the endoprosthesis is released.
The delivery catheter comprises a distal capsule that contains the endoprosthesis at its compressed state and the catheter shaft assembly that extends from within the capsule to the outer system handle. The handle maintains control knobs and/or dials and/or buttons that are connected to layers of the shaft assembly that on their other end within the capsule function to gradually open the capsule and uncover the endoprosthesis. This causes the uncovered parts of the latter to assume their default-uncompressed state and shape, allowing the inner lumen of the frame to form and the valve leaflets to commence function propelled by the blood flow. The handle also maintains functions that allow through shaft layers and or other components to resheath and remove the endoprosthesis even after full delivery and function is achieved.
The device allows for complete atraumatic re-capture/research and removal of the endoprosthesis even after its full deployment and assumption of its function.
The endoprosthesis (
The stent part of the endoprosthesis includes a crown (9), and a ring (10). The crown includes capturing elements for each of the native valve leaflets (11). Each such element has an exterior (12) and an interior part (13) for enveloping/capturing/clipping the respective native valve leaflet. The first component of the stent that expands within the left ventricle is the part of the crown that has at least two external wings/hooks/clipping elements (14), also shown in
These external elements when released are aligned using continuous real-time imaging modalities, such as transesophageal echocardiography, to extend behind (outside) each of the two native mitral valve leaflets. At the same time the tips of the interior enveloping/capturing/clipping elements start to flare (15) when the ventricular side of the capsule opens to fully release their outer counterparts. Once this is achieved the entire system is moved so that the tips of the exterior wings/hooks/clipping elements approach and contact the mitral valve annulus at its ventricular side. It is expected that when this occurs the operator will experience resistance providing tactile feedback for the correct positioning. During this initial phase the native mitral valve function is uninterrupted. The exterior elements by sitting behind the leaflets and reaching deep into the annulus create an anchoring of the entire frame on the ventricular side of the mitral annulus.
Then, and while exerting a steady force to keep the external wings/hooks/clipping parts at or as close as possible to the ventricular side of the mitral annulus, the atrial side of the capsule opens releasing the rest of the endoprosthesis frame.
The first to be released next is the part of the stent crown that holds the bases of the internal enveloping/capturing/clipping elements. These expand towards their external counterparts and capture/envelop/clip the native valve leaflets locking them into a wide-open position by doing so. By pairing these hooking components on either side of the native valve leaflets these are engulfed/enveloped/clipped in between them and as the frame keeps expanding they are locked in this position. The interior pairing constituents (13) have sufficient length to capture at least the tips of the native leaflets before they join the stent ring. They may also be made to have a progressively greater default expansion towards the annulus (16) than their exterior counterparts, and by doing so they fix the native valve leaflets actively inside (essentially by clipping them). The pairing components can have a range of shapes that pinch the native leaflets in between (12, 13). Furthermore, the capture elements of the anterior and posterior native valve leaflets may differ in shape to match the different anatomy of these leaflets. For example, the exterior elements of the anterior leaflet may be wider and longer than their interior counterparts and have a reversed M shape so that their two bases are seated closer to the fibrous trigones on both sides of the anterior leaflets (
After the stent crown is released and the native valve leaflets are locked wide open in it, the ring of the stent is released. The stent ring has a fabric skirt layer attached for sealing the areas of the annulus it apposes to from unwanted blood flow. The shape of the ring may be rather oval and in any case resembling and conforming optimally with the shape of the mitral valve annulus. Externally it may have anchoring elements such as hooks, barbs, spikes, indentations or similar (17) to secure on the annulus as it apposes against it, and provide additional stabilization of the endoprosthesis at the annulus on this occasion. These anchoring features are mainly found towards the perimeter of the stent that apposes to the commissural areas of the annulus. Maximal radial strength is given at the larger diameter of the stent. The radial strength of the stent arc that apposes the annulus at the root of the anterior leaflet is calculated so that it does not push the leaflet into the outflow tract of the left ventricle and cause obstruction. For the same reason, the clipping mechanism of the anterior leaflet when fully expanded may have an incline away from the outflow tract.
In the interior part of the stent ring there are elements for passively attaching the endoprosthesis on its delivery catheter pins during the crimping process. This passive attachment offers stabilization of the endoprosthesis on its delivery catheter while the capsule components move to release various parts of it, till of course the capsule uncovers the area of the stent ring that sits on the catheter pins and releases it.
The prosthetic valve leaflets are attached to the stent ring and the interior enveloping elements of the stent crown but can also be attached at other purposely-devoted posts of the stent (
Lastly, the wire mesh part of the endoprosthesis (8) is released by continued opening of the atrial side of the capsule (
In summary, all segments offer the stabilizing mechanism of this endoprosthesis. The stent crown of the frame contains the paired elements that actively capture, envelope and lock wide open the two native valve leaflets. In addition, the bases of the exterior elements are behind the native leaflets and are immobilized by the ventricular side of the annulus. This latter segment offers also tactile feedback for the correct positioning of the endoprosthesis.
The stent ring expands and apposes the native valve annulus and has also special features for anchoring on it. Finally, the wire mesh offers stabilization at the level of the annulus and towards the atrial side and locks the endoprosthesis at its final position, offering at the same time room for self-adjustment and self-alignment.
The release of this endoprosthesis starts from the ventricle and ends in the left atrium.
The endoprosthesis can have several standardized shapes and sizes. It can even be custom made based on measurements from the patient's anatomy obtained by medical imaging.
The resheath/recapture/removal capability of the endoprosthesis, even after complete deployment, is described in the delivery catheter section.
Another version (
The elements for passively attaching of this endoprosthesis on its delivery catheter pins during the crimping process are at the most ventricular tips of the stent crown. This is the part of the endoprosthesis released last. This passive attachment offers steadiness of the endoprosthesis on its delivery catheter while the capsule components move to release various parts of it, till of course the capsule uncovers this final part.
The endoprosthesis can have several standardized shapes and sizes. It can even be custom made based on measurements from the patient's anatomy obtained by medical imaging. The prosthetic valve leaflets are attached to the stent ring and the interior enveloping elements of the stent crown but can also be attached at other areas of the wire frame.
Another version of either of the two previous embodiments (2 and 3) can have a more dominant wire mesh part that alone or with a degree of overlap with the stent part apposes at the annulus and succeeds the stabilization of this endoprosthesis (
The wire mesh of this endoprosthesis covers from just below the annulus, then covers it and extends at the surrounding atrial walls. It has a trench or channel or concavity at its outer perimeter (25) that has the shape of the annulus and slightly oversizes it, so that by expanding on the annulus sits on its both sides fixing perfectly and steadily the endoprosthesis.
The stent part in this case, connects to the wire mesh below the annulus and it is shorter. Alternatively, it may have a component to surround the wire mesh away from its outer perimeter (internally) at the level of the annulus and provide additional radial force to it (
The stent crown can also be similar to embodiment 3, and in this case the atrial part of the endoprosthesis is first deployed and pulled downward till the wire mesh seats firmly at the floor of the atrium. Then the rest of the wire mesh is deployed surrounding the annulus and finally the stent parts that hold or capture the native valve leaflets wide-open and offer additional anchoring and stabilization at the ventricular side (embodiment 4b) (
The wire mesh incorporates a fabric or other material to make it instantly impermeable and may have a fabric skirt at the level of the annulus for better sealing. The endoprosthesis can have several standardized shapes and sizes. It can even be custom made based on measurements from the patient's anatomy obtained by medical imaging.
The prosthetic valve leaflets are attached to the wire frame of the endoprosthesis at the stent part.
This version is similar to the previous embodiment 4, but the frame of this endoprosthesis is entirely formed by the wire mesh (
The atrial side is first released within the left atrium. The valve then is pulled downward till the wire mesh seats firmly at the floor of the atrium. By doing so stabilizes the endoprosthesis at the atrial level of the annulus and allows auto-adjustment of the entire endoprosthesis. It has a progressively larger default diameter at its atrial side, and it may be made to have a tendency to revert backwards and appose actively to the atrial wall on the atrial side of the annulus and above it offering superior sealing from paravalvular insufficiency and improving the stabilization of the entire frame. The dimensions of the wire mesh can differ locally to conform best to the anatomy it apposes to. The entire mesh wire can be braided. Alternatively, the most exterior parts of the wire mesh that are away from the annulus can be made of flat mesh, while as it comes closer to the annulus it becomes braided. The wire mesh incorporates a fabric or other material to make it instantly impermeable. It can also have a fabric skirt at the level of the annulus for better sealing.
Then by keeping the opened atrial part on the floor of the atrium the part that apposes at the annulus is released. This has a trench or channel or concavity at its outer perimeter that has the shape of the annulus and slightly oversizes it, so that by expanding on the annulus it sits on its both sides fixing perfectly and steadily the endoprosthesis.
The wire mesh extends more into the surrounding atrial walls than in the ventricular side of the annulus (
This endoprosthesis wire mesh frame may have one or more of the additional components: A. A collapsible wire component, such a short stent, to surround the wire mesh internally at the level of the annulus and to provide additional radial force to it at that level (27). B. Stand-alone or connected wire elements (hooks, barbs, spikes, indentations or similar) at the outer ventricular surface of the frame for anchoring below the annulus (28). C. Particular wire posts and elements for attachment of the prosthetic leaflets and for holding the native valve leaflets wide open (29).
The wire mesh incorporates a fabric or other material to make it instantly impermeable and may have a fabric skirt at the level of the annulus for better sealing. The endoprosthesis can have several standardized shapes and sizes. It can even be custom made based on measurements from the patient's anatomy obtained by medical imaging.
The prosthetic valve leaflets are attached to the wire frame of the endoprosthesis. This endoprosthesis can be deployed either from its atrial or its ventricular side.
This embodiment describes an endoprosthesis, which is a version of either the embodiments 2-4 endoprosthesis. The main feature of this version that makes it distinct from those embodiments is that the stent part of the endoprosthesis frame is dominant and occupies the majority or the entire length of the frame, with the wire mesh part being exterior to it forming a body around it (
The wire mesh (30) default shape and dimensions are to out-expand the mitral valve annulus towards the atrium to allow the seating, sealing and stabilization of the endoprosthesis at its atrial side. Then the wire mesh continues as a band surrounding the stent at the annulus area and may reach just below it. This part of the wire mesh seals the endoprosthesis at the annular level. It allows the stent to appose within it and compresses on the surrounding tissues offering an optimal adaptation and stabilization at this level.
The dominant stent part in this embodiment takes advantage of the greater radial strength the stent provides to the entire frame and it allows for the formation of a uniform and assured lumien throughout the frame. The skirted stent reaches below the annulus but is short of the tips of the leaflets and its surrounding wire mesh seals any anatomical asymmetries.
The ventricular end of the stent comprises capturing elements (31) that offer stabilization of the endoprosthesis at the ventricular side and holding and capturing the native valve leaflets wide open.
In case the crown of this endoprosthesis is similar to embodiments 2 or 4a, the endoprosthesis is guided and navigated through the ventricle to capture/envelope the native mitral valve leaflets and then the rest of the endoprosthesis is expanded towards the atrium (embodiment 6a) (
In case the crown of this endoprosthesis is similar to embodiment 3 or 4b, the endoprosthesis is deployed from the atrium down to the lest ventricle, expanding the crown elements that trap the native mitral leaflets wide open and offer anchoring on the ventricular side of the annulus (embodiment 6b) (
The wire mesh incorporates a fabric or other material to make it instantly impermeable and may have a fabric skirt at the level of the annulus for better sealing. The stent part that is not covered by the mesh wire is skirted with a material so blocking any blood flow through its cells/struts. The endoprosthesis can have several standardized shapes and sizes. It can even be custom made based on measurements from the patient's anatomy obtained by medical imaging.
The prosthetic valve leaflets are attached to the stent of the endoprosthesis.
This endoprosthesis can be deployed either from its ventricular (embodiment 6a) or its atrial side (embodiment 6b).
This embodiment describes an endoprosthesis, which is a version of the embodiment 6 endoprosthesis. The main feature of this version that makes it distinct is that the interior capturing elements of the native mitral valve leaflets is the stent ring itself rather than parts of its crown (
The crown of the stent comprising the exterior capturing elements (32) that provide navigational guidance for the positioning and the stabilization of the endoprosthesis at the ventricular side of the mitral valve annulus (first step of deployment). They expand outside of the native leaflets and as the endoprosthesis is pushed upwards and towards the annulus they are captured by these elements. Then, by continuing the delivery of the endoprosthesis the next part of it expanding is the stent ring itself (33) that apposes against the leaflets from their interior surface. When this occurs the native valve leaflets are captured between the stent and the its external capturing elements. Then the rest of the endoprosthesis is released. This has a thin wire mesh band expanding at the level of the annulus. The wire mesh then outexpands the annulus at its atrial side offering sealing and stabilization. The most ventricular end of the stent may be wire mesh-free (
The endoprosthesis described is deployed from its ventricular side upwards and towards the atrium (embodiment 7a).
To avoid possible prolapse of the stent into the outflow of the left ventricle, a shorter part of the stent crown and its interior capturing elements (as described in endoprosthesis 6) may be preserved especially in the arc of the annulus that apposes towards the native anterior mitral leaflet (34).
In case the crown of this endoprosthesis is similar to embodiment 3, the endoprosthesis is deployed from the atrium down to the lest ventricle, expanding the crown elements that trap the native mitral leaflets wide open and offer anchoring on the ventricular side of the annulus (embodiment 7b).
The wire mesh incorporates a fabric or other material to make it instantly impermeable and may have a fabric skirt at the level of the annulus for better sealing. The stent part that is not covered by the mesh wire is skirted with a material so blocking any blood flow through its cells/struts.
The endoprosthesis can have several standardized shapes and sizes. It can even be custom made based on measurements from the patient's anatomy obtained by medical imaging.
The prosthetic valve leaflets are attached to the stent of the endoprosthesis.
This endoprosthesis can be deployed either from its ventricular side as described (embodiment 7a) or its atrial side (embodiment 7b).
The Delivery Catheter
1. Retrograde Access (Transventricular/Transapical)
The delivery catheter for the endoprosthesis of all embodiments consists of the capsule (
The capsule contains the crimped endoprosthesis. Both of its ends are conical (39) to allow smooth tracking.
For the endoprosthesis of the embodiments 1, 2 and 4a the capsule opens in two parts (
When the endoprosthesis is fully deployed and functional it is still connected to the delivery catheter with a plurality of thin wires (such as ultra thin nitinol wires) (42), or screwing wires attached at the most ventricular edge of the stent (area connecting the external and internal capturing elements). Therefore complete atraumatic removal of the endoprosthesis is still feasible. When thin wires are used, they are threaded trough the stent. If the endoprosthesis position and function is satisfactory, one end of the thin wire is pulled till the entire thread is removed from the endoprosthesis and releases it. If the endoprosthesis needs to be removed both ends of the thin wires are pulled together. Another way of reversible connection of the thin wires to the stent is with Highwayman's knots, that allow tightening the knot and tugging by pulling one end of the wire, while the knot unties easily by pulling the other end of the wire.
Finally, an alternative way of attachment is by use of screwing wires that are fixed in female parts found at the stent end.
The part of the shaft traveling inside through the capsule has an inner hollow to accommodate the guide wire (38). The shaft of this lumen allows the push and opening of the atrial segment of the capsule. An additional shaft layer travels the capsule and the endoprosthesis is crimped on it. This layer has a plurality of pins at the level of the stent ring (43) on which the stent is passively stabilized by mirroring elements at its exterior surface.
The ventricular segment of the capsule is connected to an additional shaft layer (44) that is found on the delivery system (not in the capsule). A part of this layer starting at the capsule and having sufficient length can effortlessly expand to accommodate a part of the endoprosthesis in case it needs to be removed after complete deployment. This is required because the ventricular segment of the capsule is smaller and cannot accommodate the entire length of the collapsing stent and wire mesh. The entire length of the endoprosthesis needs to be sheathed in order the atrial capsule part to come close, meet and attach its ventricular part and the entire capsule safely removed.
When the delivery is considered successful and the holding wires are removed, the empty atrial capsule segment is withdrawn to meet and attach to the also empty ventricular capsule segment and then the capsule is closed and removed in one piece (
The shaft of the delivery system that connects the capsule to the handle has the previously described layers plus a space (could be in the form of an additional lumen) to accommodate the retracting holding wires of the endoprosthesis (45).
The handle is where all the above-described components of the shaft culminate. It has a central lumen for the guide wire to exit (46) and all the necessary knobs/dials/wheels (47) to facilitate the independent motions of the two capsule segments, and the thin wires that are used to resheath and remove the valve if needed. It is envisaged that one knob/dial/wheel is required for the movement of the atrial capsule, one for the movement of the ventricular capsule and possibly one for the pulling of the holding wires.
The delivery catheter is advanced in the left ventricle by itself or through a guide sheath. The guide sheath and/or the delivery catheter can have flexing capabilities to assist the coaxial and central to the annulus positioning of the capsule before and during delivery.
Considering the endoprostheses of the embodiments 3, 4b and 5 the delivery catheter is similar, but the capsule does not split into two parts, and it opens from its atrial tip towards the ventricle (the endoprosthesis of the embodiment 1 can also be released such a way) (
The wire frame of the endoprosthesis and the course of the anchoring structures allow for complete retrieval of the endoprosthesis even after complete release.
The unnecessary parts of the delivery catheter for delivering this endoprosthesis are omitted (such as the separate shaft layer for the stabilization pins of the endoprosthesis and the handle wheel for moving the atrial segment of the capsule). A plurality of holding wires for retrieval of the endoprosthesis is reversibly attached (as described before) at the tips of the anchoring or other structures of the stent crown. By pulling these, the endoprosthesis reenters into the delivery capsule.
2. Antegrade Access (Transeptal, or Direct Approach)
The delivery catheter for the endoprosthesis of all embodiments consists of the endoprosthesis capsule, the shaft and the handle (
The capsule contains the collapsed and crimped endoprosthesis. Its both ends are conical to allow smooth tracking forward and backward.
For the endoprosthesis of the embodiments 1, 2 and 4a the capsule opens in two parts, the atrial part is longer and the ventricular part is shorter (
Finally, an alternative way of attachment is by use of screwing wires that are fixed in female parts in the mesh.
The part of the shaft traveling inside through the capsule has an inner lumen to accommodate the guide wire. The shaft of this lumen allows the push and opening of the ventricular segment of the capsule. An additional shaft layer travels the capsule and the endoprosthesis is crimped on it. This layer has a plurality of pins at the level of the stent ring on which the stent is passively stabilized by mirroring elements at its exterior surface.
The atrial segment of the capsule is connected to an additional shaft layer that is found on the delivery system (not in the capsule). This withdraws the atrial segment of the capsule, to completely release the endoprosthesis.
A part of this layer starting at the capsule and having sufficient length can effortlessly expand to accommodate a part of the endoprosthesis in case this needs to be removed after complete deployment. This is required because the entire length of the endoprosthesis needs to be sheathed into the atrial segment of the capsule. This additional space is required for the length of the stent that used to be accommodated into the ventricular capsule. The entire length of the endoprosthesis needs to be sheathed into the atrial capsule for the ventricular capsule segment to attach and close the capsule for safe removal.
If the deployment is not satisfactory, the wire mesh is first resheathed into the longer atrial capsule. The small part of the endoprosthesis that used to be accommodated into the ventricular capsule is also retracted into the atrial capsule, as described. When the delivery is considered successful and the holding wires are removed, the empty ventricular capsule segment is withdrawn to meet and attach to the also empty atrial capsule segment and they are then removed en block.
The shaft of the delivery system that connects the capsule to the handle has the previously described layers plus a space (could be in the form of an additional lumen) to accommodate the holding/retracting wires of the endoprosthesis.
The handle is where all the above-described components of the shaft culminate. It has a central lumen for the guiding wire to exit and all the necessary knobs/dials to facilitate the independent motions of the two capsule segments, and the wires that can be used to resheath and remove the valve if needed. It is envisaged that one knob/dial is required for the movement of the atrial capsule, one for the movement of the ventricular capsule and possibly one for the pulling of the holding wires.
The delivery catheter is advanced in the left atrium through a transeptal sheath or with direct access. The transeptal sheath and/or the delivery catheter can have flexing capabilities to assist the coaxial and central to the annulus positioning of the capsule before and during delivery.
Considering the endoprostheses of the embodiments 3, 4b and 5, the delivery catheter is similar, but the capsule does not split into two parts, and it opens from its atrial tip towards the ventricle (the endoprosthesis of the embodiment 1 can also be released such a way) (
The wire frame of the endoprosthesis and the course of the anchoring structures allow for complete retrieval of the endoprosthesis even after complete release.
A plurality of holding wires for retrieval of the endoprosthesis is reversibly attached (as described before) at the atrial edges of the wire mesh. By pulling these, the endoprosthesis reenters into the atrial segment of the delivery capsule.
In summary, the claimed inventions provide for all aspects of a successful transcatheter prosthetic mitral valve. They resolve the problems related to the uneven anatomy of the mitral valve by offering remedies at the level of the mitral valve leaflets (capture in a wide-open position and stabilization at the ventricular side), at the level of the annulus (optimal apposition, sealing and stabilization by the prosthetic valve frame) and at the level of the atrial floor (optimal apposition, sealing and stabilization by the prosthetic valve frame).
These are achieved with: 1. A refined combination of two components in the frame of the endoprosthesis, namely the wire stent contributing optimal radial strength for the formation of the frame lumen and the orifice of the prosthetic valve and the wire mesh contributing plasticity and optimal conformation. 2. An innovative method to capture and immobilize the native valve leaflets and navigationally guides the deployment of the prosthetic valve offering tactile feedback and at the same time the much-required stabilization at the ventricular level.
Number | Date | Country | Kind |
---|---|---|---|
20140100595 | Nov 2014 | GR | national |
This application is a continuation of U.S. application Ser. No. 16/740,916, filed Jan. 13, 2020, now U.S. Pat. No. 11,559,395, which is a continuation of U.S. application Ser. No. 15/526,810, filed May 15, 2017, now U.S. Pat. No. 10,531,951, which is a U.S. National Stage entry of International Application No. PCT/EP2015/077856, filed on Nov. 26, 2015, which claims priority to Greek Patent Application No. 20140100595, filed on Nov. 26, 2014, each of which is hereby incorporated by reference herein in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3409013 | Berry | Nov 1968 | A |
3472230 | Fogarty | Oct 1969 | A |
3548417 | Kisher | Dec 1970 | A |
3587115 | Shiley | Jun 1971 | A |
3657744 | Ersek | Apr 1972 | A |
3671979 | Moulopoulos | Jun 1972 | A |
3714671 | Edwards et al. | Feb 1973 | A |
3739402 | Cooley et al. | Jun 1973 | A |
3755823 | Hancock | Sep 1973 | A |
4035849 | Angell et al. | Jul 1977 | A |
4056854 | Boretos et al. | Nov 1977 | A |
4079468 | Liotta et al. | Mar 1978 | A |
4106129 | Carpentier et al. | Aug 1978 | A |
4204283 | Bellhouse et al. | May 1980 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4265694 | Boretos et al. | May 1981 | A |
4297749 | Davis et al. | Nov 1981 | A |
4339831 | Johnson | Jul 1982 | A |
4340977 | Brownlee et al. | Jul 1982 | A |
4343048 | Ross et al. | Aug 1982 | A |
4345340 | Rosen | Aug 1982 | A |
4373216 | Klawitter | Feb 1983 | A |
4406022 | Roy | Sep 1983 | A |
4470157 | Love | Sep 1984 | A |
4477930 | Totten et al. | Oct 1984 | A |
4490859 | Black et al. | Jan 1985 | A |
4535483 | Klawitter et al. | Aug 1985 | A |
4553545 | Maass et al. | Nov 1985 | A |
4574803 | Storz | Mar 1986 | A |
4592340 | Boyles | Jun 1986 | A |
4605407 | Black et al. | Aug 1986 | A |
4612011 | Kautzky | Sep 1986 | A |
4643732 | Pietsch et al. | Feb 1987 | A |
4655771 | Wallsten | Apr 1987 | A |
4692164 | Dzemeshkevich et al. | Sep 1987 | A |
4733665 | Palmaz | Mar 1988 | A |
4759758 | Gabbay | Jul 1988 | A |
4762128 | Rosenbluth | Aug 1988 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4787899 | Lazarus | Nov 1988 | A |
4787901 | Baykut | Nov 1988 | A |
4796629 | Grayzel | Jan 1989 | A |
4829990 | Thuroff et al. | May 1989 | A |
4851001 | Taheri | Jul 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4865600 | Carpentier et al. | Sep 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4878906 | Lindemann et al. | Nov 1989 | A |
4883458 | Shiber | Nov 1989 | A |
4922905 | Strecker | May 1990 | A |
4966604 | Reiss | Oct 1990 | A |
4979939 | Shiber | Dec 1990 | A |
4986830 | Owens et al. | Jan 1991 | A |
4994077 | Dobben | Feb 1991 | A |
5007896 | Shiber | Apr 1991 | A |
5026366 | Leckrone | Jun 1991 | A |
5032128 | Alonso | Jul 1991 | A |
5037434 | Lane | Aug 1991 | A |
5047041 | Samuels | Sep 1991 | A |
5059177 | Towne et al. | Oct 1991 | A |
5080668 | Bolz et al. | Jan 1992 | A |
5085635 | Cragg | Feb 1992 | A |
5089015 | Ross | Feb 1992 | A |
5108370 | Walinsky | Apr 1992 | A |
5152771 | Sabbaghian et al. | Oct 1992 | A |
5163953 | Vince | Nov 1992 | A |
5167628 | Boyles | Dec 1992 | A |
5192297 | Hull | Mar 1993 | A |
5232446 | Arney | Aug 1993 | A |
5266073 | Wall | Nov 1993 | A |
5282847 | Trescony et al. | Feb 1994 | A |
5295958 | Shturman | Mar 1994 | A |
5326371 | Love et al. | Jul 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5360444 | Kusuhara | Nov 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5397351 | Pavcnik et al. | Mar 1995 | A |
5411055 | Kane | May 1995 | A |
5411522 | Trott | May 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5415667 | Frater | May 1995 | A |
5443446 | Shturman | Aug 1995 | A |
5480424 | Cox | Jan 1996 | A |
5500014 | Quijano et al. | Mar 1996 | A |
5545209 | Roberts et al. | Aug 1996 | A |
5545214 | Stevens | Aug 1996 | A |
5549665 | Vesely et al. | Aug 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5571175 | Vanney et al. | Nov 1996 | A |
5591185 | Kilmer et al. | Jan 1997 | A |
5599305 | Hermann et al. | Feb 1997 | A |
5607464 | Trescony et al. | Mar 1997 | A |
5609626 | Quijano et al. | Mar 1997 | A |
5639274 | Fischell et al. | Jun 1997 | A |
5665115 | Cragg | Sep 1997 | A |
5697382 | Love et al. | Dec 1997 | A |
5716417 | Girard et al. | Feb 1998 | A |
5728068 | Leone et al. | Mar 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5756476 | Epstein et al. | May 1998 | A |
5769812 | Stevens et al. | Jun 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
5855597 | Jayaraman | Jan 1999 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5855602 | Angell | Jan 1999 | A |
5906619 | Olson et al. | May 1999 | A |
5925063 | Khosravi | Jul 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5968068 | Dehdashtian et al. | Oct 1999 | A |
6027525 | Suh et al. | Feb 2000 | A |
6042607 | Williamson, IV et al. | Mar 2000 | A |
6086612 | Jansen | Jul 2000 | A |
6113631 | Jansen | Sep 2000 | A |
6132473 | Williams et al. | Oct 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6171335 | Wheatley et al. | Jan 2001 | B1 |
6174327 | Mertens et al. | Jan 2001 | B1 |
6210408 | Chandrasekaran et al. | Apr 2001 | B1 |
6217585 | Houser et al. | Apr 2001 | B1 |
6221091 | Khosravi | Apr 2001 | B1 |
6231602 | Carpentier et al. | May 2001 | B1 |
6245040 | Inderbitzen et al. | Jun 2001 | B1 |
6245100 | Davila | Jun 2001 | B1 |
6245102 | Jayaraman | Jun 2001 | B1 |
6251093 | Valley et al. | Jun 2001 | B1 |
6287339 | Vazquez et al. | Sep 2001 | B1 |
6299637 | Shaolian et al. | Oct 2001 | B1 |
6302906 | Goecoechea et al. | Oct 2001 | B1 |
6306141 | Jervis | Oct 2001 | B1 |
6312465 | Griffin et al. | Nov 2001 | B1 |
6350277 | Kocur | Feb 2002 | B1 |
6358277 | Duran | Mar 2002 | B1 |
6379372 | Dehdashtian et al. | Apr 2002 | B1 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6440164 | Matteo et al. | Aug 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6461382 | Cao | Oct 2002 | B1 |
6468660 | Ogle et al. | Oct 2002 | B2 |
6482228 | Norred | Nov 2002 | B1 |
6488704 | Connelly et al. | Dec 2002 | B1 |
6527800 | McGuckin, Jr. et al. | Mar 2003 | B1 |
6527979 | Constantz | Mar 2003 | B2 |
6540782 | Snyders | Apr 2003 | B1 |
6569196 | Vesely | May 2003 | B1 |
6575959 | Sarge et al. | Jun 2003 | B1 |
6582462 | Andersen et al. | Jun 2003 | B1 |
6605112 | Moll et al. | Aug 2003 | B1 |
6610088 | Gabbay | Aug 2003 | B1 |
6629534 | St. Goar et al. | Oct 2003 | B1 |
6676698 | McGuckin, Jr. et al. | Jan 2004 | B2 |
6695878 | McGuckin, Jr. et al. | Feb 2004 | B2 |
6712836 | Berg et al. | Mar 2004 | B1 |
6716207 | Farnholtz | Apr 2004 | B2 |
6729356 | Baker et al. | May 2004 | B1 |
6730118 | Spenser et al. | May 2004 | B2 |
6733525 | Yang et al. | May 2004 | B2 |
6746422 | Noriega et al. | Jun 2004 | B1 |
6749560 | Konstorum et al. | Jun 2004 | B1 |
6767362 | Schreck | Jul 2004 | B2 |
6780200 | Jansen | Aug 2004 | B2 |
6790229 | Berreklouw | Sep 2004 | B1 |
6790230 | Beyersdorf et al. | Sep 2004 | B2 |
6830584 | Seguin | Dec 2004 | B1 |
6875231 | Anduiza et al. | Apr 2005 | B2 |
6893460 | Spenser et al. | May 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
6974476 | McGuckin, Jr. et al. | Dec 2005 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7186265 | Sharkawy et al. | Mar 2007 | B2 |
7192440 | Andreas et al. | Mar 2007 | B2 |
7198646 | Figulla et al. | Apr 2007 | B2 |
7201772 | Schwammenthal et al. | Apr 2007 | B2 |
7276078 | Spenser et al. | Oct 2007 | B2 |
7276084 | Yang et al. | Oct 2007 | B2 |
7318278 | Zhang et al. | Jan 2008 | B2 |
7374571 | Pease et al. | May 2008 | B2 |
7381210 | Zarbatany et al. | Jun 2008 | B2 |
7381219 | Salahieh et al. | Jun 2008 | B2 |
7393360 | Spenser et al. | Jul 2008 | B2 |
7429269 | Schwammenthal et al. | Sep 2008 | B2 |
7442204 | Schwammenthal et al. | Oct 2008 | B2 |
7445631 | Salahieh et al. | Nov 2008 | B2 |
7462191 | Spenser et al. | Dec 2008 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7524330 | Berreklouw | Apr 2009 | B2 |
7530253 | Spenser et al. | May 2009 | B2 |
7553324 | Andreas et al. | Jun 2009 | B2 |
7579381 | Dove | Aug 2009 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7618446 | Andersen et al. | Nov 2009 | B2 |
7621948 | Herrmann et al. | Nov 2009 | B2 |
7704222 | Wilk et al. | Apr 2010 | B2 |
7736327 | Wilk et al. | Jun 2010 | B2 |
7748389 | Salahieh et al. | Jul 2010 | B2 |
7753949 | Lamphere et al. | Jul 2010 | B2 |
7806919 | Bloom et al. | Oct 2010 | B2 |
7824443 | Salahieh et al. | Nov 2010 | B2 |
7837727 | Goetz et al. | Nov 2010 | B2 |
7892281 | Seguin et al. | Feb 2011 | B2 |
7914569 | Nguyen et al. | Mar 2011 | B2 |
7914575 | Guyenot et al. | Mar 2011 | B2 |
7959672 | Salahieh et al. | Jun 2011 | B2 |
7972378 | Tabor et al. | Jul 2011 | B2 |
7981151 | Rowe | Jul 2011 | B2 |
7993392 | Righini et al. | Aug 2011 | B2 |
7993394 | Hariton et al. | Aug 2011 | B2 |
8007992 | Tian et al. | Aug 2011 | B2 |
8016877 | Seguin et al. | Sep 2011 | B2 |
8029556 | Rowe | Oct 2011 | B2 |
8052750 | Tuval et al. | Nov 2011 | B2 |
8070800 | Lock et al. | Dec 2011 | B2 |
8070802 | Lamphere et al. | Dec 2011 | B2 |
8075615 | Eberhardt et al. | Dec 2011 | B2 |
8080054 | Rowe | Dec 2011 | B2 |
8092520 | Quadri | Jan 2012 | B2 |
8092521 | Figulla et al. | Jan 2012 | B2 |
8109996 | Stacchino et al. | Feb 2012 | B2 |
8118866 | Herrmann et al. | Feb 2012 | B2 |
8136218 | Millwee et al. | Mar 2012 | B2 |
8137398 | Tuval et al. | Mar 2012 | B2 |
8157852 | Bloom et al. | Apr 2012 | B2 |
8167932 | Bourang | May 2012 | B2 |
8167934 | Styrc et al. | May 2012 | B2 |
8182530 | Huber | May 2012 | B2 |
8206437 | Bonhoeffer et al. | Jun 2012 | B2 |
8216174 | Wilk et al. | Jul 2012 | B2 |
8216301 | Bonhoeffer et al. | Jul 2012 | B2 |
8219229 | Cao et al. | Jul 2012 | B2 |
8220121 | Hendriksen et al. | Jul 2012 | B2 |
8236045 | Benichou et al. | Aug 2012 | B2 |
8246675 | Zegdi | Aug 2012 | B2 |
8246678 | Salahieh et al. | Aug 2012 | B2 |
8252051 | Chau et al. | Aug 2012 | B2 |
8252052 | Salahieh et al. | Aug 2012 | B2 |
8287584 | Salahieh et al. | Oct 2012 | B2 |
8313525 | Tuval et al. | Nov 2012 | B2 |
8317858 | Straubinger et al. | Nov 2012 | B2 |
8323335 | Rowe et al. | Dec 2012 | B2 |
8337541 | Quadri et al. | Dec 2012 | B2 |
8353953 | Giannetti et al. | Jan 2013 | B2 |
8398704 | Straubinger et al. | Mar 2013 | B2 |
8403983 | Quadri et al. | Mar 2013 | B2 |
8414644 | Quadri et al. | Apr 2013 | B2 |
8414645 | Dwork et al. | Apr 2013 | B2 |
8416643 | Magee | Apr 2013 | B2 |
8444689 | Zhang | May 2013 | B2 |
8449599 | Chau et al. | May 2013 | B2 |
8454685 | Hariton et al. | Jun 2013 | B2 |
8460368 | Taylor et al. | Jun 2013 | B2 |
8460370 | Zakay | Jun 2013 | B2 |
8470023 | Eidenschink et al. | Jun 2013 | B2 |
8470028 | Thornton et al. | Jun 2013 | B2 |
8475521 | Suri et al. | Jul 2013 | B2 |
8475523 | Duffy | Jul 2013 | B2 |
8479380 | Malewicz et al. | Jul 2013 | B2 |
8491650 | Wiemeyer et al. | Jul 2013 | B2 |
8500733 | Watson | Aug 2013 | B2 |
8500798 | Rowe et al. | Aug 2013 | B2 |
8511244 | Holecek et al. | Aug 2013 | B2 |
8512401 | Murray, III et al. | Aug 2013 | B2 |
8518096 | Nelson | Aug 2013 | B2 |
8518106 | Duffy et al. | Aug 2013 | B2 |
8562663 | Mearns et al. | Oct 2013 | B2 |
8579963 | Tabor | Nov 2013 | B2 |
8579964 | Lane et al. | Nov 2013 | B2 |
8591570 | Revuelta et al. | Nov 2013 | B2 |
8617236 | Paul et al. | Dec 2013 | B2 |
8640521 | Righini et al. | Feb 2014 | B2 |
8647381 | Essinger et al. | Feb 2014 | B2 |
8652145 | Maimon et al. | Feb 2014 | B2 |
8652201 | Oberti et al. | Feb 2014 | B2 |
8652202 | Alon et al. | Feb 2014 | B2 |
8652203 | Quadri et al. | Feb 2014 | B2 |
8668733 | Haug et al. | Mar 2014 | B2 |
8679174 | Ottma et al. | Mar 2014 | B2 |
8679404 | Liburd et al. | Mar 2014 | B2 |
8685086 | Navia et al. | Apr 2014 | B2 |
8721708 | Seguin et al. | May 2014 | B2 |
8721714 | Kelley | May 2014 | B2 |
8728154 | Alkhatib | May 2014 | B2 |
8728155 | Montorfano et al. | May 2014 | B2 |
8740974 | Lambrecht et al. | Jun 2014 | B2 |
8740976 | Tran et al. | Jun 2014 | B2 |
8747458 | Tuval et al. | Jun 2014 | B2 |
8747459 | Nguyen et al. | Jun 2014 | B2 |
8758432 | Solem | Jun 2014 | B2 |
8764818 | Gregg | Jul 2014 | B2 |
8771344 | Tran et al. | Jul 2014 | B2 |
8778020 | Gregg et al. | Jul 2014 | B2 |
8784337 | Voeller et al. | Jul 2014 | B2 |
8784478 | Tuval et al. | Jul 2014 | B2 |
8784481 | Alkhatib et al. | Jul 2014 | B2 |
8790387 | Nguyen et al. | Jul 2014 | B2 |
8795357 | Yohanan et al. | Aug 2014 | B2 |
8808356 | Braido et al. | Aug 2014 | B2 |
8828078 | Salahieh et al. | Sep 2014 | B2 |
8828079 | Thielen et al. | Sep 2014 | B2 |
8834564 | Tuval et al. | Sep 2014 | B2 |
8858620 | Salahieh et al. | Oct 2014 | B2 |
8870948 | Erzberger et al. | Oct 2014 | B1 |
8870950 | Hacohen | Oct 2014 | B2 |
8876893 | Dwork et al. | Nov 2014 | B2 |
8911455 | Quadri et al. | Dec 2014 | B2 |
8926693 | Duffy et al. | Jan 2015 | B2 |
8926694 | Costello | Jan 2015 | B2 |
8939960 | Rosenman et al. | Jan 2015 | B2 |
8945209 | Bonyuet et al. | Feb 2015 | B2 |
8961593 | Bonhoeffer et al. | Feb 2015 | B2 |
8961595 | Alkhatib | Feb 2015 | B2 |
8974524 | Yeung et al. | Mar 2015 | B2 |
8979922 | Jayasinghe et al. | Mar 2015 | B2 |
8986375 | Garde et al. | Mar 2015 | B2 |
8998980 | Shipley et al. | Apr 2015 | B2 |
9005273 | Salahieh et al. | Apr 2015 | B2 |
9011521 | Haug et al. | Apr 2015 | B2 |
9011523 | Seguin | Apr 2015 | B2 |
9011524 | Eberhardt | Apr 2015 | B2 |
9028545 | Taylor | May 2015 | B2 |
9034032 | McLean et al. | May 2015 | B2 |
9055937 | Rowe et al. | Jun 2015 | B2 |
9066801 | Kovalsky et al. | Jun 2015 | B2 |
9078749 | Lutter et al. | Jul 2015 | B2 |
9078751 | Naor | Jul 2015 | B2 |
9125738 | Figulla et al. | Sep 2015 | B2 |
9173737 | Hill et al. | Nov 2015 | B2 |
9180004 | Alkhatib | Nov 2015 | B2 |
9186249 | Rolando et al. | Nov 2015 | B2 |
9277990 | Klima et al. | Mar 2016 | B2 |
9277993 | Gamarra et al. | Mar 2016 | B2 |
9289291 | Gorman, III et al. | Mar 2016 | B2 |
9295551 | Straubinger et al. | Mar 2016 | B2 |
9445897 | Bishop et al. | Sep 2016 | B2 |
9456877 | Weitzner et al. | Oct 2016 | B2 |
9681968 | Goetz et al. | Jun 2017 | B2 |
9687345 | Rabito et al. | Jun 2017 | B2 |
9700329 | Metzger et al. | Jul 2017 | B2 |
9700411 | Klima et al. | Jul 2017 | B2 |
9724083 | Quadri et al. | Aug 2017 | B2 |
9730790 | Quadri et al. | Aug 2017 | B2 |
9730791 | Ratz et al. | Aug 2017 | B2 |
9795479 | Lim et al. | Oct 2017 | B2 |
9833313 | Board et al. | Dec 2017 | B2 |
9861473 | Lafontaine | Jan 2018 | B2 |
9861476 | Salahieh et al. | Jan 2018 | B2 |
9861477 | Backus et al. | Jan 2018 | B2 |
9867698 | Kovalsky et al. | Jan 2018 | B2 |
9877830 | Lim et al. | Jan 2018 | B2 |
9889029 | Li et al. | Feb 2018 | B2 |
9895225 | Rolando et al. | Feb 2018 | B2 |
9925045 | Creaven et al. | Mar 2018 | B2 |
10004599 | Rabito et al. | Jun 2018 | B2 |
10117744 | Ratz et al. | Nov 2018 | B2 |
10179044 | Ratz et al. | Jan 2019 | B2 |
10219897 | Essinger et al. | Mar 2019 | B2 |
10350065 | Quadri | Jul 2019 | B2 |
10350066 | Cooper et al. | Jul 2019 | B2 |
10376363 | Quadri et al. | Aug 2019 | B2 |
10531951 | Spargias | Jan 2020 | B2 |
10555809 | Hastings et al. | Feb 2020 | B2 |
10575951 | Johnson et al. | Mar 2020 | B2 |
10583000 | Ratz et al. | Mar 2020 | B2 |
10639146 | Quadri et al. | May 2020 | B2 |
10695177 | Hariton et al. | Jun 2020 | B2 |
10758344 | Hariton et al. | Sep 2020 | B2 |
11406499 | Zhang et al. | Aug 2022 | B2 |
11452598 | Essinger et al. | Sep 2022 | B2 |
11559395 | Spargias | Jan 2023 | B2 |
11672658 | Hariton et al. | Jun 2023 | B2 |
11701225 | Hammer et al. | Jul 2023 | B2 |
11903829 | Ma et al. | Feb 2024 | B1 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20020032481 | Gabbay | Mar 2002 | A1 |
20020045929 | Diaz | Apr 2002 | A1 |
20020052644 | Shaolian et al. | May 2002 | A1 |
20020173842 | Buchanan | Nov 2002 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030100939 | Yodfat et al. | May 2003 | A1 |
20030105517 | White et al. | Jun 2003 | A1 |
20030120333 | Ouriel et al. | Jun 2003 | A1 |
20030130729 | Paniagua et al. | Jul 2003 | A1 |
20030158597 | Quiachon et al. | Aug 2003 | A1 |
20030176914 | Rabkin et al. | Sep 2003 | A1 |
20030199971 | Tower et al. | Oct 2003 | A1 |
20030212454 | Scott et al. | Nov 2003 | A1 |
20030220683 | Minasian et al. | Nov 2003 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040092858 | Wilson et al. | May 2004 | A1 |
20040117009 | Cali et al. | Jun 2004 | A1 |
20040133263 | Dusbabek et al. | Jul 2004 | A1 |
20040133273 | Cox | Jul 2004 | A1 |
20040186563 | Lobbi | Sep 2004 | A1 |
20040186565 | Schreck | Sep 2004 | A1 |
20040210307 | Khairkhahan | Oct 2004 | A1 |
20040215325 | Penn et al. | Oct 2004 | A1 |
20040225353 | McGuckin et al. | Nov 2004 | A1 |
20040236411 | Sarac et al. | Nov 2004 | A1 |
20040260389 | Case et al. | Dec 2004 | A1 |
20050033398 | Seguin | Feb 2005 | A1 |
20050075727 | Wheatley | Apr 2005 | A1 |
20050090887 | Pryor | Apr 2005 | A1 |
20050096738 | Cali et al. | May 2005 | A1 |
20050107872 | Mensah et al. | May 2005 | A1 |
20050137682 | Justino | Jun 2005 | A1 |
20050137686 | Salahieh et al. | Jun 2005 | A1 |
20050137687 | Salahieh et al. | Jun 2005 | A1 |
20050137688 | Salahieh et al. | Jun 2005 | A1 |
20050137691 | Salahieh et al. | Jun 2005 | A1 |
20050137698 | Salahieh et al. | Jun 2005 | A1 |
20050159811 | Lane | Jul 2005 | A1 |
20050182486 | Gabbay | Aug 2005 | A1 |
20050203614 | Forster et al. | Sep 2005 | A1 |
20050203617 | Forster et al. | Sep 2005 | A1 |
20050216079 | MaCoviak | Sep 2005 | A1 |
20050234546 | Nugent et al. | Oct 2005 | A1 |
20050288766 | Plain et al. | Dec 2005 | A1 |
20060020327 | Lashinski et al. | Jan 2006 | A1 |
20060025857 | Bergheim et al. | Feb 2006 | A1 |
20060058872 | Salahieh et al. | Mar 2006 | A1 |
20060095115 | Bladillah et al. | May 2006 | A1 |
20060142837 | Haverkost et al. | Jun 2006 | A1 |
20060149350 | Patel et al. | Jul 2006 | A1 |
20060161249 | Realyvasquez et al. | Jul 2006 | A1 |
20060173537 | Yang et al. | Aug 2006 | A1 |
20060195134 | Crittenden | Aug 2006 | A1 |
20060195183 | Navia et al. | Aug 2006 | A1 |
20060212110 | Osborne et al. | Sep 2006 | A1 |
20060229719 | Marquez et al. | Oct 2006 | A1 |
20060241745 | Solem | Oct 2006 | A1 |
20060259135 | Navia et al. | Nov 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060276874 | Wilson et al. | Dec 2006 | A1 |
20060293745 | Carpentier et al. | Dec 2006 | A1 |
20070005131 | Taylor | Jan 2007 | A1 |
20070010877 | Salahieh et al. | Jan 2007 | A1 |
20070027534 | Bergheim et al. | Feb 2007 | A1 |
20070043435 | Seguin et al. | Feb 2007 | A1 |
20070050021 | Johnson | Mar 2007 | A1 |
20070066863 | Rafiee et al. | Mar 2007 | A1 |
20070088431 | Bourang et al. | Apr 2007 | A1 |
20070100432 | Case et al. | May 2007 | A1 |
20070100439 | Cangialosi et al. | May 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070129794 | Realyvasquez | Jun 2007 | A1 |
20070142906 | Figulla et al. | Jun 2007 | A1 |
20070156224 | Cioanta et al. | Jul 2007 | A1 |
20070203503 | Salahieh et al. | Aug 2007 | A1 |
20070203575 | Forster et al. | Aug 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070255394 | Ryan | Nov 2007 | A1 |
20070270943 | Solem et al. | Nov 2007 | A1 |
20080021546 | Patz et al. | Jan 2008 | A1 |
20080065011 | Marchand et al. | Mar 2008 | A1 |
20080071361 | Tuval et al. | Mar 2008 | A1 |
20080071362 | Tuval et al. | Mar 2008 | A1 |
20080071363 | Tuval et al. | Mar 2008 | A1 |
20080071366 | Tuval et al. | Mar 2008 | A1 |
20080071368 | Tuval et al. | Mar 2008 | A1 |
20080071369 | Tuval et al. | Mar 2008 | A1 |
20080082164 | Friedman | Apr 2008 | A1 |
20080082165 | Wilson et al. | Apr 2008 | A1 |
20080082166 | Styrc et al. | Apr 2008 | A1 |
20080097581 | Shanley | Apr 2008 | A1 |
20080114442 | Mitchell et al. | May 2008 | A1 |
20080125853 | Bailey et al. | May 2008 | A1 |
20080147179 | Cai et al. | Jun 2008 | A1 |
20080147183 | Styrc | Jun 2008 | A1 |
20080154355 | Benichou et al. | Jun 2008 | A1 |
20080177381 | Navia et al. | Jul 2008 | A1 |
20080183273 | Mesana et al. | Jul 2008 | A1 |
20080208328 | Antocci et al. | Aug 2008 | A1 |
20080208332 | Lamphere et al. | Aug 2008 | A1 |
20080221672 | Lamphere et al. | Sep 2008 | A1 |
20080228254 | Ryan | Sep 2008 | A1 |
20080255660 | Guyenot et al. | Oct 2008 | A1 |
20080255661 | Straubinger et al. | Oct 2008 | A1 |
20080281411 | Berreklouw | Nov 2008 | A1 |
20090005863 | Goetz et al. | Jan 2009 | A1 |
20090054968 | Bonhoeffer et al. | Feb 2009 | A1 |
20090054974 | McGuckin, Jr. et al. | Feb 2009 | A1 |
20090076598 | Salahieh et al. | Mar 2009 | A1 |
20090112309 | Jaramillo et al. | Apr 2009 | A1 |
20090138079 | Tuval et al. | May 2009 | A1 |
20090157175 | Benichou | Jun 2009 | A1 |
20090164005 | Dove et al. | Jun 2009 | A1 |
20090171432 | Von Segesser et al. | Jul 2009 | A1 |
20090171447 | Von Segesser et al. | Jul 2009 | A1 |
20090171456 | Kveen et al. | Jul 2009 | A1 |
20090182413 | Burkart et al. | Jul 2009 | A1 |
20090188964 | Orlov | Jul 2009 | A1 |
20090216310 | Straubinger et al. | Aug 2009 | A1 |
20090216313 | Straubinger et al. | Aug 2009 | A1 |
20090216322 | Le et al. | Aug 2009 | A1 |
20090222076 | Figulla et al. | Sep 2009 | A1 |
20090234443 | Ottma et al. | Sep 2009 | A1 |
20090240320 | Tuval et al. | Sep 2009 | A1 |
20090270972 | Lane | Oct 2009 | A1 |
20090276027 | Glynn | Nov 2009 | A1 |
20090276040 | Rowe et al. | Nov 2009 | A1 |
20090281618 | Hill et al. | Nov 2009 | A1 |
20090281619 | Le et al. | Nov 2009 | A1 |
20090287296 | Manasse | Nov 2009 | A1 |
20090287299 | Tabor et al. | Nov 2009 | A1 |
20090292350 | Eberhardt et al. | Nov 2009 | A1 |
20090306768 | Quadri | Dec 2009 | A1 |
20090319037 | Rowe et al. | Dec 2009 | A1 |
20100016958 | St. Goar et al. | Jan 2010 | A1 |
20100049313 | Alon et al. | Feb 2010 | A1 |
20100069852 | Kelley | Mar 2010 | A1 |
20100114305 | Kang et al. | May 2010 | A1 |
20100131054 | Tuval et al. | May 2010 | A1 |
20100137979 | Tuval et al. | Jun 2010 | A1 |
20100174362 | Straubinger et al. | Jul 2010 | A1 |
20100191326 | Alkhatib | Jul 2010 | A1 |
20100204781 | Alkhatib | Aug 2010 | A1 |
20100217382 | Chau et al. | Aug 2010 | A1 |
20100249894 | Oba et al. | Sep 2010 | A1 |
20100249911 | Alkhatib | Sep 2010 | A1 |
20100256723 | Murray | Oct 2010 | A1 |
20100262231 | Tuval et al. | Oct 2010 | A1 |
20100305685 | Millwee et al. | Dec 2010 | A1 |
20110015616 | Straubinger et al. | Jan 2011 | A1 |
20110015729 | Jimenez et al. | Jan 2011 | A1 |
20110137397 | Chau et al. | Jun 2011 | A1 |
20110208290 | Straubinger et al. | Aug 2011 | A1 |
20110208297 | Tuval et al. | Aug 2011 | A1 |
20110208298 | Tuval et al. | Aug 2011 | A1 |
20110224785 | Hacohen | Sep 2011 | A1 |
20110238159 | Guyenot et al. | Sep 2011 | A1 |
20110264196 | Savage et al. | Oct 2011 | A1 |
20110264198 | Murray, III et al. | Oct 2011 | A1 |
20110288634 | Tuval et al. | Nov 2011 | A1 |
20110313515 | Quadri et al. | Dec 2011 | A1 |
20110319989 | Lane et al. | Dec 2011 | A1 |
20120022639 | Hacohen et al. | Jan 2012 | A1 |
20120035722 | Tuval | Feb 2012 | A1 |
20120041550 | Salahieh et al. | Feb 2012 | A1 |
20120046741 | Tuval et al. | Feb 2012 | A1 |
20120046742 | Tuval et al. | Feb 2012 | A1 |
20120078360 | Rafiee | Mar 2012 | A1 |
20120101570 | Tuval et al. | Apr 2012 | A1 |
20120101571 | Thambar et al. | Apr 2012 | A1 |
20120101572 | Kovalsky et al. | Apr 2012 | A1 |
20120123529 | Levi et al. | May 2012 | A1 |
20120185039 | Tuval et al. | Jul 2012 | A1 |
20120197386 | Von Segesser et al. | Aug 2012 | A1 |
20120209374 | Bonhoeffer et al. | Aug 2012 | A1 |
20120215303 | Quadri et al. | Aug 2012 | A1 |
20120271398 | Essinger et al. | Oct 2012 | A1 |
20120283823 | Bonhoeffer et al. | Nov 2012 | A1 |
20120290062 | McNamara et al. | Nov 2012 | A1 |
20120296418 | Bonyuet et al. | Nov 2012 | A1 |
20120310328 | Olson et al. | Dec 2012 | A1 |
20120310336 | Figulla et al. | Dec 2012 | A1 |
20130006294 | Kashkarov et al. | Jan 2013 | A1 |
20130035759 | Gross et al. | Feb 2013 | A1 |
20130073035 | Tuval et al. | Mar 2013 | A1 |
20130079869 | Straubinger et al. | Mar 2013 | A1 |
20130190861 | Chau et al. | Jul 2013 | A1 |
20130190862 | Pintor et al. | Jul 2013 | A1 |
20130197622 | Mitra et al. | Aug 2013 | A1 |
20130211508 | Lane et al. | Aug 2013 | A1 |
20130253635 | Straubinger et al. | Sep 2013 | A1 |
20130253642 | Brecker | Sep 2013 | A1 |
20130310928 | Morriss | Nov 2013 | A1 |
20130331929 | Mitra et al. | Dec 2013 | A1 |
20130338766 | Hastings et al. | Dec 2013 | A1 |
20130345786 | Behan | Dec 2013 | A1 |
20140018912 | Delaloye et al. | Jan 2014 | A1 |
20140025163 | Padala et al. | Jan 2014 | A1 |
20140039611 | Lane et al. | Feb 2014 | A1 |
20140052237 | Lane et al. | Feb 2014 | A1 |
20140100651 | Kheradvar et al. | Apr 2014 | A1 |
20140163668 | Rafiee | Jun 2014 | A1 |
20140172077 | Bruchman et al. | Jun 2014 | A1 |
20140172083 | Bruchman et al. | Jun 2014 | A1 |
20140194981 | Menk et al. | Jul 2014 | A1 |
20140207231 | Hacohen et al. | Jul 2014 | A1 |
20140214157 | Bortlein et al. | Jul 2014 | A1 |
20140222139 | Nguyen et al. | Aug 2014 | A1 |
20140222142 | Kovalsky et al. | Aug 2014 | A1 |
20140222144 | Eberhardt et al. | Aug 2014 | A1 |
20140243966 | Garde et al. | Aug 2014 | A1 |
20140257467 | Lane et al. | Sep 2014 | A1 |
20140277390 | Ratz et al. | Sep 2014 | A1 |
20140277412 | Bortlein et al. | Sep 2014 | A1 |
20140277422 | Ratz et al. | Sep 2014 | A1 |
20140277427 | Ratz et al. | Sep 2014 | A1 |
20140296973 | Bergheim et al. | Oct 2014 | A1 |
20140296975 | Tegels et al. | Oct 2014 | A1 |
20140303719 | Cox et al. | Oct 2014 | A1 |
20140309728 | Dehdashtian et al. | Oct 2014 | A1 |
20140324160 | Benichou et al. | Oct 2014 | A1 |
20140324164 | Gross et al. | Oct 2014 | A1 |
20140330368 | Gloss et al. | Nov 2014 | A1 |
20140330371 | Gloss et al. | Nov 2014 | A1 |
20140330372 | Weston et al. | Nov 2014 | A1 |
20140336754 | Gurskis et al. | Nov 2014 | A1 |
20140343669 | Lane et al. | Nov 2014 | A1 |
20140343670 | Bakis et al. | Nov 2014 | A1 |
20140350666 | Righini | Nov 2014 | A1 |
20140350668 | Delaloye et al. | Nov 2014 | A1 |
20140358223 | Rafiee et al. | Dec 2014 | A1 |
20140364939 | Deshmukh et al. | Dec 2014 | A1 |
20140364943 | Conklin | Dec 2014 | A1 |
20140371842 | Marquez et al. | Dec 2014 | A1 |
20140371844 | Dale et al. | Dec 2014 | A1 |
20140371847 | Madrid et al. | Dec 2014 | A1 |
20140371848 | Murray, III et al. | Dec 2014 | A1 |
20150005863 | Para | Jan 2015 | A1 |
20150018944 | O'Connell et al. | Jan 2015 | A1 |
20150039083 | Rafiee | Feb 2015 | A1 |
20150142103 | Vidlund | May 2015 | A1 |
20150148731 | McNamara et al. | May 2015 | A1 |
20150173897 | Raanani et al. | Jun 2015 | A1 |
20150196390 | Ma et al. | Jul 2015 | A1 |
20150209141 | Braido et al. | Jul 2015 | A1 |
20150272737 | Dale et al. | Oct 2015 | A1 |
20150297346 | Duffy et al. | Oct 2015 | A1 |
20150305860 | Wang | Oct 2015 | A1 |
20150335429 | Morriss et al. | Nov 2015 | A1 |
20150351903 | Morriss et al. | Dec 2015 | A1 |
20150359629 | Ganesan et al. | Dec 2015 | A1 |
20160000591 | Lei et al. | Jan 2016 | A1 |
20160030169 | Shahriari | Feb 2016 | A1 |
20160030170 | Alkhatib et al. | Feb 2016 | A1 |
20160030171 | Quijano et al. | Feb 2016 | A1 |
20160038281 | Delaloye et al. | Feb 2016 | A1 |
20160074160 | Christianson et al. | Mar 2016 | A1 |
20160106537 | Christianson et al. | Apr 2016 | A1 |
20160113765 | Ganesan et al. | Apr 2016 | A1 |
20160113768 | Ganesan et al. | Apr 2016 | A1 |
20160143732 | Glimsdale | May 2016 | A1 |
20160158010 | Lim et al. | Jun 2016 | A1 |
20160166383 | Lim et al. | Jun 2016 | A1 |
20160184097 | Lim et al. | Jun 2016 | A1 |
20160199206 | Lim et al. | Jul 2016 | A1 |
20160213473 | Hacohen et al. | Jul 2016 | A1 |
20160235529 | Ma et al. | Aug 2016 | A1 |
20160279386 | Dale et al. | Sep 2016 | A1 |
20160310267 | Zeng et al. | Oct 2016 | A1 |
20170128209 | Morriss et al. | May 2017 | A1 |
20170216023 | Lane et al. | Aug 2017 | A1 |
20170216575 | Asleson et al. | Aug 2017 | A1 |
20170258614 | Griffin | Sep 2017 | A1 |
20170325954 | Perszyk | Nov 2017 | A1 |
20170348096 | Anderson | Dec 2017 | A1 |
20170367821 | Landon et al. | Dec 2017 | A1 |
20170367823 | Hariton et al. | Dec 2017 | A1 |
20180021129 | Peterson et al. | Jan 2018 | A1 |
20180055629 | Oba et al. | Mar 2018 | A1 |
20180055636 | Valencia et al. | Mar 2018 | A1 |
20180085218 | Eidenschink | Mar 2018 | A1 |
20180110534 | Gavala et al. | Apr 2018 | A1 |
20180116790 | Ratz et al. | May 2018 | A1 |
20190008639 | Landon et al. | Jan 2019 | A1 |
20190008640 | Cooper et al. | Jan 2019 | A1 |
20190262129 | Cooper et al. | Aug 2019 | A1 |
20200000579 | Manash et al. | Jan 2020 | A1 |
20200108225 | Jamal et al. | Apr 2020 | A1 |
20200345494 | Srinimukesh et al. | Nov 2020 | A1 |
20200352718 | Rowe et al. | Nov 2020 | A1 |
20210145576 | Becerra et al. | May 2021 | A1 |
20210378817 | Nia et al. | Dec 2021 | A1 |
20210386544 | Cooper et al. | Dec 2021 | A1 |
20220142777 | Scheinblum et al. | May 2022 | A1 |
20220287836 | Landon et al. | Sep 2022 | A1 |
20220346993 | Srinimukesh et al. | Nov 2022 | A1 |
20230000624 | Okabe et al. | Jan 2023 | A1 |
20230200980 | Peterson et al. | Jun 2023 | A1 |
20230218391 | Dass et al. | Jul 2023 | A1 |
20230380963 | Kaufman et al. | Nov 2023 | A1 |
20230390052 | Okafor et al. | Dec 2023 | A1 |
20230404753 | Luong et al. | Dec 2023 | A1 |
20240008978 | Nawalakhe et al. | Jan 2024 | A1 |
Number | Date | Country |
---|---|---|
2304325 | Oct 2000 | CA |
2246526 | Mar 1973 | DE |
19532846 | Mar 1997 | DE |
19546692 | Jun 1997 | DE |
19857887 | Jul 2000 | DE |
19907646 | Aug 2000 | DE |
10010074 | Oct 2001 | DE |
10049812 | Apr 2002 | DE |
10049813 | Apr 2002 | DE |
10049814 | Apr 2002 | DE |
10049815 | Apr 2002 | DE |
102006052564 | Dec 2007 | DE |
0103546 | Mar 1984 | EP |
0144167 | Jun 1985 | EP |
0592410 | Apr 1994 | EP |
0597967 | May 1994 | EP |
0850607 | Jul 1998 | EP |
1057460 | Dec 2000 | EP |
1088529 | Apr 2001 | EP |
1171059 | Jan 2002 | EP |
1239901 | Sep 2002 | EP |
1255510 | Nov 2002 | EP |
1259194 | Nov 2002 | EP |
1369098 | Dec 2003 | EP |
1469797 | Oct 2004 | EP |
1472996 | Nov 2004 | EP |
1570809 | Sep 2005 | EP |
1653888 | May 2006 | EP |
1849440 | Oct 2007 | EP |
1935377 | Jun 2008 | EP |
2124826 | Dec 2009 | EP |
2168536 | Mar 2010 | EP |
2413842 | Feb 2012 | EP |
2446915 | May 2012 | EP |
2745805 | Jun 2014 | EP |
2749254 | Jul 2014 | EP |
2750630 | Jul 2014 | EP |
2777616 | Sep 2014 | EP |
2777617 | Sep 2014 | EP |
2918249 | Sep 2015 | EP |
2948103 | Dec 2015 | EP |
2967858 | Jan 2016 | EP |
3037064 | Jun 2016 | EP |
3046511 | Jul 2016 | EP |
3057541 | Aug 2016 | EP |
3075354 | Oct 2016 | EP |
3139864 | Mar 2017 | EP |
3142603 | Mar 2017 | EP |
3184083 | Jun 2017 | EP |
3294220 | Mar 2018 | EP |
3417813 | Dec 2018 | EP |
3570779 | Nov 2019 | EP |
2788217 | Jul 2000 | FR |
2815844 | May 2002 | FR |
1264471 | Feb 1972 | GB |
1315844 | May 1973 | GB |
2056023 | Mar 1981 | GB |
2398245 | Aug 2004 | GB |
1271508 | Nov 1986 | SU |
9116041 | Oct 1991 | WO |
9117720 | Nov 1991 | WO |
9217118 | Oct 1992 | WO |
9301768 | Feb 1993 | WO |
9724080 | Jul 1997 | WO |
9829057 | Jul 1998 | WO |
9933414 | Jul 1999 | WO |
9940964 | Aug 1999 | WO |
9947075 | Sep 1999 | WO |
0047139 | Aug 2000 | WO |
03047468 | Jun 2003 | WO |
03092554 | Nov 2003 | WO |
2004030569 | Apr 2004 | WO |
2004100652 | Nov 2004 | WO |
2005011534 | Feb 2005 | WO |
2005034812 | Apr 2005 | WO |
2005087140 | Sep 2005 | WO |
2005102015 | Nov 2005 | WO |
2006014233 | Feb 2006 | WO |
2006034008 | Mar 2006 | WO |
2006085225 | Aug 2006 | WO |
2006100034 | Sep 2006 | WO |
2006108090 | Oct 2006 | WO |
2006111391 | Oct 2006 | WO |
2006138173 | Dec 2006 | WO |
2007025028 | Mar 2007 | WO |
2008005405 | Jan 2008 | WO |
2008035337 | Mar 2008 | WO |
2008125153 | Oct 2008 | WO |
2008147964 | Dec 2008 | WO |
2008150529 | Dec 2008 | WO |
2009024859 | Feb 2009 | WO |
2009026563 | Feb 2009 | WO |
2009042196 | Apr 2009 | WO |
2009091509 | Jul 2009 | WO |
2009094500 | Jul 2009 | WO |
2010005524 | Jan 2010 | WO |
2010008549 | Jan 2010 | WO |
2010121076 | Oct 2010 | WO |
2011002996 | Jan 2011 | WO |
2011081997 | Jul 2011 | WO |
2012008459 | Jan 2012 | WO |
2012032187 | Mar 2012 | WO |
2012095455 | Jul 2012 | WO |
2013005878 | Jan 2013 | WO |
2013028387 | Feb 2013 | WO |
2013106585 | Jul 2013 | WO |
2014009213 | Jan 2014 | WO |
2014018432 | Jan 2014 | WO |
2014079291 | May 2014 | WO |
2014145338 | Sep 2014 | WO |
2014149865 | Sep 2014 | WO |
2014163706 | Oct 2014 | WO |
2014194178 | Dec 2014 | WO |
2015004624 | Jan 2015 | WO |
2015004625 | Jan 2015 | WO |
2015057407 | Apr 2015 | WO |
2015077274 | May 2015 | WO |
2016002189 | Jan 2016 | WO |
2016004137 | Jan 2016 | WO |
2016016899 | Feb 2016 | WO |
2017006510 | Jan 2017 | WO |
2017035487 | Mar 2017 | WO |
2018000333 | Jan 2018 | WO |
2018213209 | Nov 2018 | WO |
2022002054 | Jan 2022 | WO |
2023006048 | Feb 2023 | WO |
2023076103 | May 2023 | WO |
2023081236 | May 2023 | WO |
2023091769 | May 2023 | WO |
2023096804 | Jun 2023 | WO |
2023154250 | Aug 2023 | WO |
2023196150 | Oct 2023 | WO |
2023244454 | Dec 2023 | WO |
2023244767 | Dec 2023 | WO |
2023250114 | Dec 2023 | WO |
2024001789 | Jan 2024 | WO |
2024003620 | Jan 2024 | WO |
2024007575 | Jan 2024 | WO |
2024009540 | Jan 2024 | WO |
2024010739 | Jan 2024 | WO |
2024030520 | Feb 2024 | WO |
Entry |
---|
Al Zaibag et al., “Percutaneous Balloon Valvotomy in Tricuspid Stenosis”, British Heart Journal, vol. 57, No. 1, Jan. 1987. |
Al-Khaja et al., “Eleven years' experience with Carpentier-Edwards biological valves in relation to survival and complications”, European Journal of Cardio-Thoracic Surgery, vol. 3, No. 4, pp. 305-311, Jul. 1, 1989, Springer-Verlag, Berlin, Germany. |
Almagor et al., “Balloon Expandable Stent Implantation in Stenotic Right Heart Valved Conduits”, Journal of the American College of Cardiology, vol. 16, No. 5, pp. 1310-1314, Nov. 15, 1990. |
Andersen, et al., “Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs”, European Heart Journal, vol. 13, No. 5, pp. 704-708, May 1, 1992, The European Society of Cardiology, Oxford University Press, United Kingdom. |
Andersen, H.R. “History of Percutaneous Aortic Valve Prosthesis,” Herz, vol. 34., No. 5, pp. 343-346, Aug. 2009, Urban & Vogel, Germany. |
Backer, Ole De, MD, et al., “Percutaneous Transcatheter Mitral Valve Replacement—An Overview of Devices in Preclinical and Early Clinical Evaluation,” Contemporary Reviews in Interventional Cardiology, Circ Cardiovasc Interv. 2014;7:400-409, Applicant believes this may have been available as early as Jun. of 2014. |
Banai, Shmeul et al., The Journal of the American College of Cardiology, “Transapical Mitral Implantation of the Tiara Bioprosthesis Pre-Clinical Results,” Feb. 2014, <http://interventions. onlinejacc.org/article. aspx?articleid=1831234>. |
Benchimol et al., “Simultaneous left ventricular echocardiography and aortic blood velocity during rapid right ventricular pacing in man”, The American Journal of the Medical Sciences, vol. 273, No. 1, pp. 55-62, Jan.-Feb. 1977, Elsevier, United States. |
Berreklouw, Eric, PhD, et al., “Sutureless Mitral Valve Replacement With Bioprostheses and Nitinol Attachment Rings: Feasibility in Acute Pig Experiments,” The Journal of Thoracic and Cardiovascular Surgery, vol. 142, No. 2, Aug. 2011 in 7 pages, Applicant believes this may have been available online as early as Feb. 7, 2011. |
Dake et al., “Transluminal Placement of Endovascular Stent-Grafts for the Treatment of Descending Thoracic Aortic Aneurysms”, The New England Journal of Medicine, vol. 331, No. 26, pp. 1729-1734, Dec. 29, 1994. |
Dotter et al., “Transluminal Treatment of Arteriosclerotic Obstruction: Description of a New Technic and a Preliminary Report of Its Application”, Circulation, vol. XXX, No. 30, pp. 654-670, Nov. 1, 1964, Lippincott Williams & Wilkins, Philadelphia, PA. |
Inoune et al., “Clinical application of transvenous mitral commissurotomy by a new balloon catheter,” The Journal of Thoracic and Cardiovascular Surgery, vol. 87, No. 3, pp. 394-402, Mar. 1984, Elsevier, United States. |
Kolata, Gina “Device That Opens Clogged Arteries Gets a Failing Grade in a New Study”, The New York Times, Jan. 3, 1991, pp. 1-2 [online], [retrieved on Jul. 29, 2009]. Retrieved from the Internet <URL:http://www.nytimes.com/1991/01/03/health/device-that-opens-clogged-arteries-gets-a-faili . . . . |
Lawrence, Jr., et al., “Percutaneous Endovascular Graft: Experimental Evaluation”, Cardiovascular Radiology 163, pp. 357-360, May 1987. |
Pavcnik et al., “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Radiology, vol. 183, No. 1, pp. 151-154, Apr. 1, 1992. Elsevier, United States. |
Porstmann et al., “Der Verschluß des Ductus Arteriosus Persistens Ohne Thorakotomie”, Thoraxchirurgie Vaskulare Chirurgie, Band 15, Heft 2, Stuttgart, im Apr. 1967, pp. 199-203. |
Sabbah et al., “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview”, Journal of Cardiac Surgery, vol. 4, No. 4, pp. 302-309, Dec. 1989. |
Selby et al., “Experience with New Retrieval Forceps for Foreign Body Removal in the Vascular, Urinary, and Biliary Systems”, Radiology, vol. 176, No. 2, pp. 535-538, Jul. 31, 1990, Radiological Society of North America, Oak Brook, IL. |
Serruys et al., “Stenting of coronary arteries. Are we the sorcerer's apprentice?”, European Heart Journal, vol. 10, No. 9 pp. 774-782, Sep. 1, 1989, The European Society of Cardiology, Oxford University Press, United Kingdom. |
Sigwart, Ulrich, “An Overview of Intravascular Stents: Old and New,” Textbook of Interventional Cardiology, Second Edition, chapter 48, pp. 803-815, © 1994, W.B. Saunders Company, Philadelphia, PA. |
Uchida et al., “Modifications of Gianturco Expandable Wire Stents”, Technical Note, American Roentgen Ray Society, pp. 1185-1187, May 1988. |
Urban, Philip MD, “Coronary Artery Stenting”, pp. 5-47, © 1991, ISBN: 2-88049-054-5, Editions Medecine et Hygiene, Geneva, Switzerland. |
Watt et al., “Intravenous adenosine in the treatment of supraventricular rachycardia: a dose-ranging study and interaction with dipyridamole”, British Journal of Clinical Pharmacology, vol. 21, No. 2, pp. 227-230, Feb. 1986, British Pharmacological Society, London, United Kingdom. |
Wheatley, David J., “Valve Prosthesis”, Rob & Smith's Operative Surgery—Cardiac Surgery, vol. 91, No. 2, pp. 415-424, Feb. 1, 1987, Butterworth Scientific, London, UK. |
Number | Date | Country | |
---|---|---|---|
20230157818 A1 | May 2023 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16740916 | Jan 2020 | US |
Child | 18095979 | US | |
Parent | 15526810 | US | |
Child | 16740916 | US |